Vldlr overexpression causes hyperactivity in rats

Molecular Autism

Volumn 3, Issue 1, 2012, Pages

  Iwata, Keiko ^a   Izumo, Nobuo ^b   Matsuzaki, Hideo ^a   Manabe, Takayuki ^c   Ishibashi, Yukiko ^b   Ichitani, Yukio ^d   Yamada, Kazuo ^d   Thanseem, Ismail ^e   Anitha, Ayyappan ^a   Vasu, Mahesh Mundalil ^e   Shimmura, Chie ^e   Wakuda, Tomoyasu ^e   Kameno, Yosuke ^e   Takahashi, Taro ^a   Iwata, Yasuhide ^e   Suzuki, Katsuaki ^a   Nakamura, Kazuhiko ^e   Mori, Norio ^e  

^a Molecular Research Center for Children's Mental Development   (Japan)

^b YOKOHAMA COLLEGE OF PHARMACY   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hyperactivity; Neurodevelopmental disorder; Psychiatric disorder; Reelin; Transgenic rat; Vldlr

Indexed keywords

MESSENGER RNA; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HYPERACTIVITY; LOCOMOTION; MAZE TEST; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT; WORKING MEMORY;

MUS; RATTUS;

EID: 84871723626     PISSN: None     EISSN: 20402392     Source Type: Journal    
DOI: 10.1186/2040-2392-3-11     Document Type: Article

References (48)

1. A YAC contig containing the reeler locus with preliminary characterization of candidate gene fragments. Bar I, Lambert De Rouvroit C, Royaux I, Krizman D, Dernoncourt C, Ruelle D, Beckers M, Goffinet A, Genomics 1995 26 543 549 10.1016/0888-7543(95)80173-J 7607678
2. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. D'Arcangelo G, Miao G, Chen S, Soares H, Morgan J, Curran T, Nature 1995 374 719 723 10.1038/374719a0 7715726
3. Reelin is a serine protease of the extracellular matrix. Quattrocchi C, Wannenes F, Persico A, Ciafré S, D'Arcangelo G, Farace M, Keller F, J Biol Chem 2002 277 303 309 11689558 (Pubitemid 34952059)
4. Involvement of Cajal-Retzius neurons in spontaneous correlated activity of embryonic and postnatal layer 1 from wild-type and reeler mice. Aguiló A, Schwartz T, Kumar V, Peterlin Z, Tsiola A, Soriano E, Yuste R, J Neurosci 1999 19 10856 10868 10594067 (Pubitemid 30235730)
5. The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Ogawa M, Miyata T, Nakajima K, Yagyu K, Seike M, Ikenaka K, Yamamoto H, Mikoshiba K, Neuron 1995 14 899 912 10.1016/0896-6273(95)90329-1 7748558
6. Segregation and coactivation of developing neocortical layer 1 neurons. Soda T, Nakashima R, Watanabe D, Nakajima K, Pastan I, Nakanishi S, J Neurosci 2003 23 6272 6279 12867512 (Pubitemid 36875629)
7. Reelin is a ligand for lipoprotein receptors. D'Arcangelo G, Homayouni R, Keshvara L, Rice D, Sheldon M, Curran T, Neuron 1999 24 471 479 10.1016/S0896-6273(00)80860-0 10571240 (Pubitemid 29508420)
8. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Hiesberger T, Trommsdorff M, Howell B, Goffinet A, Mumby M, Cooper J, Herz J, Neuron 1999 24 481 489 10.1016/S0896-6273(00)80861-2 10571241 (Pubitemid 29508421)
9. Receptor clustering is involved in reelin signaling. Strasser V, Fasching D, Hauser C, Mayer H, Bock H, Hiesberger T, Herz J, Weeber E, Sweatt J, Pramatarova A, Howell B, Schneider W, Nimpf J, Mol Cell Biol 2004 24 1378 1386 10.1128/MCB.24.3.1378-1386.2004 14729980 (Pubitemid 38112197)
10. Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophrenia. Ballmaier M, Zoli M, Leo G, Agnati L, Spano P, Eur J Neurosci 2002 15 1197 1205 10.1046/j.1460-9568.2002.01952.x 11982630 (Pubitemid 35463620)
11. Disruption of reelin signaling attenuates methamphetamine-induced hyperlocomotion. Matsuzaki H, Minabe Y, Nakamura K, Suzuki K, Iwata Y, Sekine Y, Tsuchiya K, Sugihara G, Suda S, Takei N, Nakahara D, Hashimoto K, Nairn A, Mori N, Sato K, Eur J Neurosci 2007 25 3376 3384 10.1111/j.1460-9568.2007.05564.x 17553006 (Pubitemid 46872764)
12. Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Baldo B, Kelley A, Psychopharmacology (Berl) 2007 191 439 459 10.1007/s00213-007-0741-z (Pubitemid 46355910)
13. Effects of cocaine context on NAcc dopamine and behavioral activity after repeated intravenous cocaine administration. Duvauchelle C, Ikegami A, Asami S, Robens J, Kressin K, Castaneda E, Brain Res 2000 862 49 58 10.1016/S0006- 8993(00)02091-6 10799668 (Pubitemid 30229769)
14. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Gong W, Neill D, Lynn M, Justice JJ, Neuroscience 1999 93 1349 1358 10.1016/S0306- 4522(99)00235-3 10501459 (Pubitemid 29397563)
15. Conditioned locomotor activity but not conditioned place preference following intra-accumbens infusions of cocaine. Hemby S, Jones G, Justice JJ, Neill D, Psychopharmacology (Berl) 1992 106 330 336 10.1007/BF02245413
16. Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Pijnenburg A, Honig W, van der Heyden J, van Rossum J, Eur J Pharmacol 1976 35 45 58 10.1016/0014-2999(76)90299-5 3421
17. Letter. Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. Pijnenburg A, van Rossum J, J Pharm Pharmacol 1973 25 1003 1005 4150283
18. Altered performance of reelin-receptor ApoER2 deficient mice on spatial tasks using the Barnes maze. Barr A, MacLaurin S, Semenova S, Fish K, Markou A, Behav Neurosci 2007 121 1101 1105 17907841 (Pubitemid 350051312)
19. Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Beffert U, Weeber E, Durudas A, Qiu S, Masiulis I, Sweatt J, Li W, Adelmann G, Frotscher M, Hammer R, Herz J, Neuron 2005 47 567 579 10.1016/j.neuron.2005.07.007 16102539 (Pubitemid 41139214)
20. Apoer2: a reelin receptor to remember. D'Arcangelo G, Neuron 2005 47 471 473 10.1016/j.neuron.2005.08.001 16102527 (Pubitemid 41139203)
21. Assessment of cognitive function in the heterozygous reeler mouse. Krueger D, Howell J, Hebert B, Olausson P, Taylor J, Nairn A, Psychopharmacology (Berl) 2006 189 95 104 10.1007/s00213-006-0530-0 (Pubitemid 44607263)
22. Olfactory discrimination learning deficit in heterozygous reeler mice. Larson J, Hoffman J, Guidotti A, Costa E, Brain Res 2003 971 40 46 10.1016/S0006-8993(03)02353-9 12691835 (Pubitemid 36412062)
23. Differential reelin-induced enhancement of NMDA and AMPA receptor activity in the adult hippocampus. Qiu S, Zhao L, Korwek K, Weeber E, J Neurosci 2006 26 12943 12955 10.1523/JNEUROSCI.2561-06.2006 17167084 (Pubitemid 44954613)
24. The phenotypic characteristics of heterozygous reeler mouse. Tueting P, Costa E, Dwivedi Y, Guidotti A, Impagnatiello F, Manev R, Pesold C, Neuro Report 1999 10 1329 1334 (Pubitemid 29403718)
25. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. Weeber E, Beffert U, Jones C, Christian J, Forster E, Sweatt J, Herz J, J Biol Chem 2002 277 39944 39952 10.1074/jbc.M205147200 12167620 (Pubitemid 35190981)
26. A fresh look at an ancient receptor family: emerging roles for low density lipoprotein receptors in synaptic plasticity and memory formation. Qiu S, Korwek K, Weeber E, Neurobiol Learn Mem 2006 85 16 29 10.1016/j.nlm.2005.08. 009 16198608 (Pubitemid 41786046)
27. Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Fatemi S, Mol Psychiatry 2001 6 129 133 10.1038/sj.mp.4000129 11317213 (Pubitemid 32187861)
28. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Fatemi S, Earle J, McMenomy T, Mol Psychiatry 2000 5 654 663 571 10.1038/sj.mp.4000783 11126396
29. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Fatemi S, Hossein Fatemi S, Stary J, Earle J, Araghi-Niknam M, Eagan E, Schizophr Res 2005 72 109 10.1016/j.schres.2004.02.017 15560956 (Pubitemid 39550982)
30. Reelin signaling is impaired in autism. Fatemi S, Snow A, Stary J, Araghi-Niknam M, Reutiman T, Lee S, Brooks A, Pearce D, Biol Psychiatry 2005 57 777 787 10.1016/j.biopsych.2004.12.018 15820235 (Pubitemid 40487922)
31. Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder. Fatemi S, Stary J, Egan E, Cell Mol Neurobiol 2002 22 139 152 10.1023/A:1019857620251 12363196
32. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Guidotti A, Auta J, Davis J, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson D, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E, Arch Gen Psychiatry 2000 57 1061 1069 10.1001/archpsyc.57.11.1061 11074872
33. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Impagnatiello F, Guidotti A, Pesold C, Dwivedi Y, Caruncho H, Pisu M, Uzunov D, Smalheiser N, Davis J, Pandey G, Pappas G, Tueting P, Sharma R, Costa E, Proc Natl Acad Sci USA 1998 95 15718 15723 10.1073/pnas.95.26.15718 9861036 (Pubitemid 29018766)
34. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Persico A, D'Agruma L, Maiorano N, Totaro A, Militerni R, Bravaccio C, Wassink T, Schneider C, Melmed R, Trillo S, Montecchi F, Palermo M, Pascucci T, Puglisi-Allegra S, Reichelt K, Conciatori M, Marino R, Quattrocchi C, Baldi A, Zelante L, Gasparini P, Keller F, Mol Psychiatry 2001 6 150 159 10.1038/sj.mp.4000850 11317216 (Pubitemid 32187864)
35. Decreased expression of reelin receptor VLDLR in peripheral lymphocytes of drug-naive schizophrenic patients. Suzuki K, Nakamura K, Iwata Y, Sekine Y, Kawai M, Sugihara G, Tsuchiya K, Suda S, Matsuzaki H, Takei N, Hashimoto K, Mori N, Schizophr Res 2008 98 148 156 17936586 (Pubitemid 350235901)
36. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Torrey E, Barci B, Webster M, Bartko J, Meador-Woodruff J, Knable M, Biol Psychiatry 2005 57 252 260 10.1016/j.biopsych.2004.10.019 15691526 (Pubitemid 40187369)
37. The heterozygous reeler mouse: behavioural phenotype. Podhorna J, Didriksen M, Behav Brain Res 2004 153 43 54 10.1016/j.bbr.2003.10.033 15219705 (Pubitemid 38829287)
38. Behavioral phenotype of the reeler mutant mouse: effects of RELN gene dosage and social isolation. Salinger W, Ladrow P, Wheeler C, Behav Neurosci 2003 117 1257 1275 14674845 (Pubitemid 37549427)
39. Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice. Qiu S, Korwek K, Pratt-Davis A, Peters M, Bergman M, Weeber E, Neurobiol Learn Mem 2006 85 228 242 10.1016/j.nlm.2005.11.001 16376115
40. Chronic psychotropic drug treatment causes differential expression of Reelin signaling system in frontal cortex of rats. Fatemi S, Reutiman T, Folsom T, Schizophr Res 2009 111 138 152 10.1016/j.schres.2009.03.002 19359144
41. Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart. Masuzaki H, Jingami H, Matsuoka N, Nakagawa O, Ogawa Y, Mizuno M, Yoshimasa Y, Yamamoto T, Nakao K, Circ Res 1996 78 8 14 10.1161/01.RES.78.1.8 8603509 (Pubitemid 26004115)
42. Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. Jokinen E, Landschulz K, Wyne K, Ho Y, Frykman P, Hobbs H, J Biol Chem 1994 269 26411 26418 7929362 (Pubitemid 24328463)
43. Dab1 tyrosine phosphorylation sites relay positional signals during mouse brain development. Howell BW, Herrick TM, Hildebrand JD, Zhang Y, Cooper JA, Curr Biol 2000 10 877 885 10.1016/S0960-9822(00)00608-4 10959835 (Pubitemid 30647616)
44. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, Hammer R, Richardson J, Herz J, Cell 1999 97 689 701 10.1016/S0092-8674(00)80782-5 10380922 (Pubitemid 29278044)
45. Regulation of the interaction of Disabled-1 with CIN85 by phosphorylation with Cyclin-dependent kinase 5. Sato Y, Taoka M, Sugiyama N, Kubo K, Fuchigami T, Asada A, Saito T, Nakajima K, Isobe T, Hisanaga S, Genes Cells 2007 12 1315 1327 10.1111/j.1365-2443.2007.01139.x 18076569 (Pubitemid 350215136)
46. CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice. Shimokawa N, Haglund K, Hölter S, Grabbe C, Kirkin V, Koibuchi N, Schultz C, Rozman J, Hoeller D, Qiu C, Londoño M, Ikezawa J, Jedlicka P, Stein B, Schwarzacher S, Wolfer DP, Ehrhardt N, Heuchel R, Nezis I, Brech A, Schmidt M, Fuchs H, Gailus-Durner V, Klingenspor M, Bogler O, Wurst W, Deller T, de Angelis M, Dikic I, EMBO J 2010 29 2421 2432 10.1038/emboj.2010.120 20551902
47. Neuroanatomy of autism. Amaral D, Schumann C, Nordahl C, Trends Neurosci 2008 31 137 145 10.1016/j.tins.2007.12.005 18258309
48. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders: DSM-IV American Psychiatric Association, Washington, DC 4 1994